CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
COSMO Pharmaceuticals SA Company Snapshot
COSMO Pharmaceuticals SA operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares COSMO Pharmaceuticals SA with three other pharmaceutical manufacturers in Europe: Solon Eiendom ASA of Norway (2016 sales of 691.50 million Norwegian Kroner [US$83.30 million] of which 114% was Residential Real Estate), Bioton SA of Poland (277.61 million Polish New Zlotys [US$77.76 million] of which 60% was Insulin (Bioton SA)), and Bosnalijek d.d. Sarajevo which is based in Bosnia (135.81 million Bosnian Convertible Marks [US$81.82 million] ).

Sales Analysis. COSMO Pharmaceuticals SA reported sales of 67.66 million Euro (US$79.60 million) for the year ending December of 2016. This represents an increase of 11.6% versus 2015, when the company's sales were 60.61 million Euro. Despite this increase, sales are still well below the level achieved in 2014, when COSMO Pharmaceuticals SA reported sales of 79.59 million Euro. Sales of Other Revenues From Sale saw an increase that was more than double the company's growth rate: sales were up 369.4% in 2016, from 196,000.00 Euro to 920,000.00 Euro. COSMO Pharmaceuticals SA also saw significant increases in sales in Manufacturing of Mmx Products (up 23.5% to 35.87 million Euro) and Royalties (up 58.8% to 20.21 million Euro) and Related Services (up 18.2% to 1.07 million Euro) . Not all segments of COSMO Pharmaceuticals SA experienced an increase in sales in 2016: sales of License Fees and Milestones fell 94.4% to 445,000.00 Euro. COSMO Pharmaceuticals SA also experienced decreases in sales in Manufacturing of Generic Products and Sp (down 6.0% to 9.15 million Euro) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
COSMO Pharmaceuticals SA
  Stock Performance Chart for COSMO Pharmaceuticals SA
 
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 113.65
(Figures in Euro)
1 Week -5.6%   13 Weeks -5.9%  
4 Weeks -10.1%   52 Weeks -28.8%  
 
COSMO Pharmaceuticals SA Key Data:
  Ticker: COPN Country: Luxembourg
  Exchanges: ZHR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 67,664,000
(Year Ending Jan 2017).
Employees: 217
  Currency: Euro Market Cap: 1,708,945,282
  Fiscal Yr Ends: December Shares Outstanding: 15,037,483
  Share Type: AZIONI ORDINAIRE Closely Held Shares: 7,353,371
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.